3332 Real-world treatment of vismodegib (VISMO)-related adverse events (AEs) in patients with locally advanced basal cell carcinoma: Report from the RegiSONIC Disease Registry Study
暂无分享,去创建一个
T. Olencki | M. Lacouture | A. Sekulic | Jean Y. Tang | R. Kudchadkar | K. Dawson | G. Rogers | Y. Mun | S. Yoo | J. Guillen